Anastasiou, O. E. Et Al. 2021. A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. JOURNAL OF VIRAL HEPATITIS , vol.28, no.2 , 410-419.

Anastasiou, O. E., Yurdaydin, C., Maasoumy, B., Hardtke, S., Caruntu, F. A., Curescu, M. G., ... Yalcin, K.(2021). A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction. JOURNAL OF VIRAL HEPATITIS , vol.28, no.2, 410-419.

Anastasiou, Olympia Et Al. "A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction," JOURNAL OF VIRAL HEPATITIS , vol.28, no.2, 410-419, 2021

Anastasiou, Olympia E. Et Al. "A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction." JOURNAL OF VIRAL HEPATITIS , vol.28, no.2, pp.410-419, 2021

Anastasiou, O. E. Et Al. (2021) . "A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction." JOURNAL OF VIRAL HEPATITIS , vol.28, no.2, pp.410-419.

@article{article, author={Olympia E. Anastasiou Et Al. }, title={A transient early HBV-DNA increase during PEG-IFN alpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction}, journal={JOURNAL OF VIRAL HEPATITIS}, year=2021, pages={410-419} }